Bavarian Nordic jumps as travel health unit drives outlook hike

Bavarian Nordic A/S

08/10/2026 08:44

** Shares in Bavarian Nordic BAVA.CO rise around 3% after the Danish vaccine maker raised 2026 guidance driven by its travel health business
** The biotech company sees annual revenue of around DKK 6.1 billion ($913.49 million), vs previous target of around DKK 5.7 billion, and EBITDA margin of around 32% instead of around 30%
** The new revenue guidance surpasses analysts' consensus estimate, brokerage Van Lanschot Kempen says
** The brokerage adds the upgrade was entirely based on continued strong performance in Travel Health
** Bavarian Nordic is among top performers on the Copenhagen stock exchange .OMXCPI, which slides 0.43%
($1 = 6.6777 Danish crowns)

(Reporting by Alexander Klyve Gudbrandsen)
((alexanderklyve.gudbrandsen@thomsonreuters.com))